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Abstract 
Background: Adverse temperature recording in vaccine’s cold chain is a major issue worldwide and this condition is 
known to compromise the quality of vaccines very rapidly. In Cameroon, with tropical climate, vaccines exposure to 
abnormal temperatures is very common. This study was conducted to identify factors associated to abnormal tem-
perature recording in cold chain in the North West region.
Results: A total of 65 vaccinating health facilities were visited for the study from eight health districts. Concerning 
type of health facility, 48 (73.8%) of the health facilities were governmental facilities. About 50 (76.0%) of the facilities 
had a functional thermometer. Among the 50 health facilities with functional thermometer, abnormal temperatures 
were registered in 10 (20%) health facilities during data collection and 12 (24%) in the 2 months preceding collection. 
Factor significantly associated with abnormal temperature recording was the absence of an alternative power source 
(OR = 6.5, p = 0.03).
Conclusion: The absence of an alternative source of power was significantly associated with abnormal temperature 
exposure in the 2 months preceding data collection. To improve on the quality of vaccines administered in North 
West region, each vaccinating health facility must have at least two sources of power supply.
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Background
Immunization is the most cost-effective preventive 
health intervention presently known in modern medicine 
[1, 2]. To achieve full benefits of immunization, it is nec-
essary to ensure high coverage, availability of potent vac-
cines, and timely delivery of scheduled immunizations [3, 
4]. Vaccines are biological substances that gradually lose 
their potencies with time [5]. This loss of potency can be 
accelerated when exposed to excessive heat, freeze, or 
light [5, 6]. The conservation of vaccine’s potency from 
the manufacturer down to users is still very challenging. 
The exposure of vaccines to adverse temperature condi-
tions does not only nullify the immunization effect, but 
also induces adverse events following immunization [7–
10]. Therefore, vaccines must be handled with care and a 
lot of attentions to ensure their quality and consequently 
full immunization benefit.
The role of cold chain is at the center of the Expanded 
Program on Immunization (EPI)’s activities since it main-
tains vaccines at a narrowed temperature environment 
(necessary for potency conservation) from the manufac-
turer down to the users [1, 2]. However, within the cold 
chain, maintaining the temperature is never really easy 
due to varying environmental (weather, climate, and 
human activities) conditions [11]. Also, the equipment 
of the cold chain and power supply might register failure 
at any given time [2]. Consequently, continuous moni-
toring of the cold chain is indispensable so that vaccines 
exposure to adverse temperatures must be noticed early 
enough to take action. Cold chain failure and frequent 
Open Access
*Correspondence:  martinyakum@yahoo.com 
1 Department of Biomedical Sciences, University of Dschang,  
P.O. Box 067, Dschang, Cameroon
Full list of author information is available at the end of the article
Page 2 of 7Yakum et al. BMC Res Notes  (2015) 8:277 
exposure of vaccines to adverse temperature conditions 
have been documented in several parts of the world 
[11–15].
In developed countries, exposure to freezing tem-
peratures is most frequent [15] conversely to develop-
ing countries where exposure to overheating is the most 
frequent [12, 13]. It is believed that; tropical climates, 
unreliable power sources, and limited resources (mate-
rial, financial, and human) are factors responsible for the 
frequent exposure of vaccine to overheating temperature 
conditions in developing countries [1, 2, 5].
In Cameroon, outbreaks of vaccine preventable dis-
eases are common and vaccine exposure to abnormal 
temperatures has been documented. The North West 
region is one of the regions constantly in epidemic of vac-
cine preventable diseases [16]. Also, high rate of exposure 
of vaccines to abnormal temperatures has equally been 
documented here [12]. This paper attempts to evaluate 
factors associated with vaccine exposure to adverse tem-
perature condition at primary health care and district 
levels in the North West region of Cameroon.
Methods
Study design
It was a cross sectional study targeting primary health 
care centers and district cold chains and was con-
ducted in December 2013. Sampling was done at mul-
tiple levels and data collected with a preconceived and 
validated grid by observation and consultation of the 
vaccine-related documents. Associated factors were 
tested by calculating the odds ratio (OR), confidence 
interval and P value with simple logistic regression and 
potential confounders controlled on a multiple logistic 
regression.
Setting
The North West Region of Cameroon had an estimated 
total population of 1,901,579 inhabitants for 2013 une-
venly distributed among 19 health districts and 218 
health areas. In total, there are 12 rural and 7 urban 
health districts. It lies between latitudes 5°40′ and 7° to 
the North of the equator, and between longitudes 9°45 
and 11°10′ to the East of the Meridian. It is bordered to 
the south west by the South West region, to the south 
by West region, to the east by Adamawa region, and to 
the north by the Federal Republic of Nigeria. Concerning 
the weather temperatures during the 2 months targeted 
by this study (November and December 2013), the aver-
age temperature for the month of November was 19.4°C 
(min  =  14.9°C, max  =  23.8°C) and that’s of December 
was 19.5°C (min  =  14.4°C, max  =  24.6°C). Concern-
ing power supply, about 80% of the region has access to 
electricity.
Ethical statement and authorization
The study targeted immunization’s cold chain of health 
facilities and did not have anything to do with human 
subjects or their biological or personal information. 
Therefore, ethical approval was not requested. The 
authorization to carry out the research was obtained 
from the regional delegate of Public Health for the North 
West region.
Study population
The study involved vaccinating health facility in the 
selected health districts. Eight health districts were 
selected for the study. These included: Bamenda, Bena-
kuma, Kumbo West, Ndop, Ndu, Nkambe, Tubah, and 
Wum Health Districts. Figure 1 shows the selected health 
district on the Map of the North West region, Cameroon
The Cameroon health system is divided into 3 levels: 
the central level, represented by the ministry of health; 
the intermediate level, represented by the regional del-
egations of public health; and the Peripheral level, rep-
resented by the health districts. The health district is 
managed by the district health service (DHS) which is 
headed by a district medical officer. A health district is 
made up of many health areas and each health area has 
at least one primary healthcare center which is responsi-
ble for delivering health care services to the population of 
the health area. The primary health care centers are cat-
egorized into: integrated health centers (IHC) headed by 
a senior nurse, Sub-divisional hospital headed by a medi-
cal doctor or district hospital which is headed by a medi-
cal director. Concerning cold chain management, this is 
ensured at the primary health care center by the head, 
but this function can be assigned to one of the person-
nel. The national guideline recommends that a tempera-
ture chart should be pasted on all vaccine refrigerators. 
The personnel responsible of cold chain monitoring reads 
and records vaccine temperature twice daily (morning 
and evening) on the chart. Also, all power interruptions 
are indicated on the chart. It should be noted that this 
chart is designed to collect information for 1 year. Con-
sequently, the chart is replaced at the beginning of each 
year and the previous filled one archived in the health 
facility archiving system.
Sampling
All health districts of the North West were first of all 
grouped into 7 urban and 12 rural districts. Eight (42%) 
of these health districts, that is, three urban and five 
rural districts were selected from their respective groups 
by simple random sampling technique. In each selected 
district, the list of all health facilities involved in the 
immunization activities was made and seven selected 
by systematic sampling technique. Also, the district’s 
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immunization cold chain system was evaluated. The sam-
pling procedure was adopted to ensure the representative 
of the sample and to ensure the attainment of the sample 
size (estimated at 60) needed for the study.
Data collection
Data were collected with a preconceived and validated 
grid. Data collected were on the availability and func-
tioning of vaccine refrigerator, present of cold chain 
contingency plan, presence of a source of power and 
an alternative source of power supply, presence of tem-
perature recording sheet, presence of a functional ther-
mometer in the vaccine fridge, presence of the national 
guidelines on immunization, the temperature at the 
moment of data collection. A cold chain contingency plan 
is a plan or procedure that will take effect if emergencies 
such as power interruption and refrigerator breakdown 
occur. It is also called emergency plan and the national 
guidelines recommends it to all vaccinating centers. In 
health facilities without a functional thermometer, data 
on temperature exposure could not be obtained but all 
other data were collected.
Data analysis
Data were analyzed with EpiInfo 3.5.4. In the first place, 
data forms were checked corrected and validated before 
entering into the computer. The entered data were further 
cleaned and analyzed. The availability and the functioning 
of cold chain materials were evaluated by calculating pro-
portions such as the proportion of vaccine fridge having 
a functional thermometer, proportion of health facilities 
having a cold chain contingency plan. Also, the main out-
come of interest was the abnormal temperature recorded 
during 2 months preceding data collection. Vaccines were 
said to have been exposed to adverse temperature condi-
tions if one temperature recorded in the 2  months pre-
ceding data collection was greater than +8°C or less than 
+2°C; else, the vaccines were said not exposed to adverse 
temperature conditions. Two months period was just the 
time chosen by the research team to evaluate the cold 
Figure 1 Map of Cameroon showing the North West region and the health districts. The map and the permission to use it were obtained from the 
regional delegation of public health for the North West region and the delegation is informed that the figure will be published in an open access 
journal.
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chain. The association of adverse temperature exposure 
with some potential factors was estimated by calculating 
the OR, CI, and the P value using a simple logistic regres-
sion. Potential confounder, number of refrigerator break 
down during the 2  months was controlled in a multiple 
logistic regression to obtain the adjusted OR. The confi-
dence intervals were calculated at 95% confidence.
Results
Characteristics of health facilities
A total of 65 vaccinating health facilities were visited for 
the study from 8 Health Districts. Concerning type of 
health facility, 48 (73.8 [61.5–84.0] %) of the health facili-
ties were governmental facilities and 40 (61.5 [48.6–73.3] 
%) were Integrated Health Centers (IHC). All district 
cold chains in the eight District Health Services (DHS) 
were evaluated.
Availability and functioning of cold chain
Table  1 below presents the availability and functioning 
of cold chain equipment and resources in the targeted 
health facilities.
Temperature condition of vaccine
Among the 50 health facilities that had a functioning 
thermometer in a vaccine fridge, 10 (20 [10.0–33.3] %) 
of them had a thermometer reading out of the optimal 
vaccine storage temperature of +2°C to +8°C at the 
moment of data collection. Exposure to temperature 
higher than 8°C was more frequent 6 (12%) than the 
exposure to temperature less than 2°C 4 (8%). Further-
more, from the records of the 2 months preceding data 
collection, 12 (24.0 [13.1–38.2] %) health facilities had 
recorded at least one temperature out of the optimal 
vaccine storage temperature of +2°C to  +8°C. Simi-
larly, exposure to overheat was more frequent. A total 
of 12 (24%) vaccine fridges were exposed to overheating 
(temperature higher than 8°C) and 6 (12%) exposed to 
cold (temperature lower than +2°C) in the two previous 
months to data collection. It is worth noting that all the 
vaccine refrigerators that were exposed to cold during 
the two months were equally exposed to overheating.
Factors associated with the exposure of vaccines 
to adverse temperature conditions
Table 2 presents the potential factor associated with the 
exposure of vaccine to abnormal temperature.
It should be noted that, none of the 10 health facilities 
that recorded abnormal temperature during the 2 months 
preceding data collection had a cold chain contingency 
plan whereas 12 (30%) of those with correct temperature 
had a cold chain contingency plan.
Discussion
This paper attempts to identify factors associated with 
abnormal temperature recording in vaccine’s cold chain. 
Table 1 Availability and functioning of cold chain materials and equipment
Italic values indicate statistical significance (p ≤ 0.05).
Equipment and resources Frequency (%)
Total DHS (n = 8) IHC (n = 40) Others (n = 17)
Vaccine refrigerator (n = 65)
 Present 57 (87.7) 8 (100.0) 36 (90.0) 13 (76.5)
 Functioning 53 (81.5) 8 (100.0) 32 (80.0) 13 (76.5)
Thermometer in functional refrigerators (n = 53)
 Present 51 (96.2) 8 (100.0) 30 (93.8) 13(100.0)
 Functioning 50 (94.3) 7 (87.5) 30 (93.8) 13 (100.0)
Temperature sheet on functional refrigerators (n = 53)
 Present 50 (94.3) 6 (75.0) 31 (96.9) 13 (100.0)
 Up-to-date 25 (47.2) 3 (37.5) 16 (50.0) 6 (46.2)
Cold chain contingency plan present (n = 57) 12 (21.1) 0 (0.0) 10 (27.8) 2 (15.4)
National immunization guidelines present (n = 65) 41 (63.1) 5 (62.5) 28 (70.0) 8 (47.1)
One personnel assigned to monitor cold chain (65) 50 (76.9) 8 (100.0) 28 (70.0) 14 (82.4)
Power sources (n = 65)
 Electricity 53 (81.5) 8 (100.0) 30 (75.0) 15 (88.2)
 Presence of at least two sources 41 (63.1) 4 (50.0) 24 (60.0) 13 (76.5)
Cold boxes/vaccine carriers present 65 (100.0) 8 (100.0) 40 (100.0) 17 (100.0)
Presence of icepack 65 (100.0) 8 (100.0) 40 (100.0) 17 (100.0)
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It might save as a reference, helping to identify simple 
practices capable of improving the quality of vaccine.
It came out from the results that 24% of the vaccine 
refrigerators were exposed sub-optimal temperatures 
within a 2  months period. The problem of overheating 
was documented in all refrigerators that were exposed 
to sub-optimal temperatures whereas only 67% of them 
were exposed to freezing temperatures. The absence of 
an alternative source of power supply (OR = 6.5, P = 0.03 
was associated with vaccine exposure to sub-optimal 
temperatures.
The exposure of vaccines to sub-optimal temperatures 
indicated in this paper is a worldwide problem and has 
been documented in many parts of the world [11–16]. 
This problem might be caused by factors related to the 
cold chain equipment, personnel, and/or power supplies 
[17, 18]. The rate of exposure to sub-optimal tempera-
tures may even be higher than the 24% documented here 
since exposure during transportation was not evaluated. 
For example, about 18.5% of health facility did not have 
a functional vaccine refrigerator and this implies they 
have to transport vaccines from and to the closest health 
facility with a functional cold chain before and after each 
immunization session respectively [2, 11]. This increases 
the chance of exposing vaccines to heat or freezing, and 
consequently reduces vaccine’s potency and increases 
the wastage rate [3, 11, 12]. Many research papers hold 
the opinion that freezing of vaccine is very common and 
more likely during transportation than overheating [3]. 
The paper proposes that the lack of an alternative source 
of power supply is associated with vaccines exposure to 
adverse temperature conditions. It was documented in 
a study in Nigeria that irregular power supply of health 
facilities and absence of standby generator were major 
risk factors of loss of vaccine potency [19]. Though not 
statistically significant here, the use of vaccine contin-
gency plan is recommended by national and international 
guidelines on immunization [1–5] and supervision has 
showed to increase the adverse event following immuni-
zation detection and reporting rates in Cameroon [10]. 
Therefore, to minimize the rate of exposure of vaccine 
to adverse temperature conditions, all vaccinating cent-
ers should be provided with a vaccine refrigerator and an 
alternative power supply [20]. Also, these health facili-
ties should be supervised regularly stressing on the use of 
contingency plan in all centers [21].
The need for innovative technology in cold chain moni-
toring that can help reduce the rate of vaccine exposure to 
adverse temperatures or that can lead to the production of 
thermo-stable vaccines has been well established [22–29]. 
Innovating technologies that can help target the weakness 
of cold chain identified in this paper include: production 
of thermo-stable vaccines [11, 30], computerization of 
cold chain monitoring, the use of electronic temperature 
monitor with alarm, and the production of long-life cold 
chain equipment [31]. A systematic review has docu-
mented the possibility to produce thermo-stable vaccines 
at low cost from plants [30]. The computerization and 
electronic cold chain monitoring and the production of 
long-life cold chain have equally been demonstrated [31]. 
However, the production of long-life cold chain can only 
prevent overheating but not freezing. The production of 
thermo-stable vaccines has been demonstrated only in 
some cases like the Influenza virus vaccine [30] and there 
is not yet enough evidence that it can also be done for 
other vaccines. Also, the computerization of cold chain 
monitoring and the use of electronic monitor with alarm 
have been tested and used in developed countries like the 
USA [31]. Therefore, all these innovating technologies to 
improve on cold chain still need to be tested in resource-
limited settings to enable their universal benefits.
The shortcomings of this paper include the fact that 
data were collected on vaccine only at storage and not 
during transportation; temperature records used were 
those registered twice daily which cannot actually tell 
how many times adverse temperatures occurred; and 
the fact that some health facilities refused participating 
in the study. However, Health districts and health facili-
ties were selected randomly and the surveyors were well 
trained before the start of data collection. The results of 
this study can therefore be inferred to the whole of the 
North West region.
Table 2 Potential factor associated with the exposure of vaccine to abnormal temperature
* Statistically significant association.
Factor Simple logistic regression Multiple logistic regression
OR CI P value ORadj CI P valueadj
Absence of a cold chain contingency plan 1.8 0.33–9.59 0.4990 1.5 0.28–8.53 0.6220
Absence of guidelines 1.0 0.24–4.11 0.6230 1.4 0.30–6.34 0.6792
Absence of an alternative power source 3.5 0.83–14.69 0.0843 6.5 1.14–37.05 0.0352*
Was not supervised within 2 months 1.6 0.37–6.53 0.4017 2.8 0.59–13.36 0.1874
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Conclusion
Exposure of vaccines to adverse temperature condi-
tions is a major problem in the North West region of 
Cameroon. This problem is not only grounded at health 
facilities but also at district health services which is sup-
posed to oversee and supervise the immunization related 
activities of the health facilities. The lack of an alterna-
tive source of power supply was significantly associated 
with adverse temperature exposure of vaccines. In order 
to reduce the rate of vaccine exposure to adverse tem-
peratures, we recommend the following practices to the 
regional delegation of Public Health for the North West 
region and the various district health services:
  – Ensure that each vaccinating health facility and district 
health services is provided with at least one stand-by 
source of power different from the main source.
  – Supervise the health facility regularly, not more than 
2 month per facility and insisting on the use of contin-
gency plan in all the facilities.
  – Appoint one health personnel to monitor the cold 
chain in each health facilities and district health ser-
vices.
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